Delivery Order SPE2DB24D2018-SPE2DB25FWWA3
Award Date 8/4/25
Potential Completion Date 8/5/25
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $8,191.05 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed price, competitively awarded delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The contract is not set aside and will be performed at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $12,478.85 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on June 24, 2025, with completion scheduled for June 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be performed at the vendor's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $58,100.78 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on May 5, 2025, with an ultimate completion date of May 6, 2025. This firm fixed price, non-set-aside delivery order represents a purchase of pharmaceutical inventory to support federal medical procurement needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $15,339.52 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count unit dose packages) on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,111.66 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $32,555.23 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $17,363.67 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on August 25, 2025, with completion expected by August 26, 2025. This firm fixed price, non-set-aside contract represents a routine pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the DLA's medical supply chain and...
- The Defense Logistics Agency awarded a delivery order valued at $11,404.73 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on June 6, 2025, with completion scheduled for June 9, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract carries no set-aside designation and is performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,265.94 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 26, 2025, with completion targeted for August 27, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $5,031.82 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and represents a continuation of the vendor's pharmaceutical supply support to federal healthcare systems. The contract performance location is AmerisourceBergen's corporate headquarters in Conshohocken,...